Sally Mokhtari
About
Sally Mokhtari is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, Sally Mokhtari has authored 31 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 11 papers in Oncology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sally Mokhtari's work include Hematopoietic Stem Cell Transplantation (18 papers), Acute Lymphoblastic Leukemia research (10 papers) and CAR-T cell therapy research (7 papers). Sally Mokhtari is often cited by papers focused on Hematopoietic Stem Cell Transplantation (18 papers), Acute Lymphoblastic Leukemia research (10 papers) and CAR-T cell therapy research (7 papers). Sally Mokhtari collaborates with scholars based in United States and Chile. Sally Mokhtari's co-authors include Ryotaro Nakamura, Stephen J. Forman, Monzr M. Al Malki, Haris Ali, Amandeep Salhotra, Dongyun Yang, David S. Snyder, Ibrahim Aldoss, Anthony S. Stein and Guido Marcucci and has published in prestigious journals such as Blood, Transplantation and Journal for ImmunoTherapy of Cancer.
In The Last Decade
Sally Mokhtari
29 papers receiving 282 citations
Peers
Sally Mokhtari
Igor‐Wolfgang Blau Germany
Apostolia Papalexandri Greece
Takanori Teshima Japan
Petter Svenberg Sweden
C. Filì Italy
L-P Xu China
D.C. Setubal Brazil
M. Schaffer Sweden
Jeremy Ramdial United States
S. Vigouroux France
Citations per year, relative to Sally Mokhtari Sally Mokhtari (= 1×)
peers
Igor‐Wolfgang Blau
Countries citing papers authored by Sally Mokhtari
Since
Specialization
Citations
This map shows the geographic impact of Sally Mokhtari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Mokhtari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Mokhtari more than expected).
Fields of papers citing papers by Sally Mokhtari
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Sally Mokhtari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Mokhtari. The network helps show where Sally Mokhtari may publish in the future.
Co-authorship network of co-authors of Sally Mokhtari
This figure shows the co-authorship network connecting the top 25 collaborators of Sally Mokhtari. A scholar is included among the top collaborators of Sally Mokhtari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Mokhtari. Sally Mokhtari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Salhotra, Amandeep, Dongyun Yang, Sally Mokhtari, et al.. (2024). Phase 1 Trial Investigating the Safety and Tolerability of Leflunomide in Patients with Steroid-Dependent Chronic Graft-Versus-Host Disease (cGVHD) after Allogeneic Hematopoietic Cell Transplant (alloHCT). Transplantation and Cellular Therapy. 30(2). S282–S283.
2.
Malki, Monzr M. Al, Joycelynne Palmer, Ni‐Chun Tsai, et al.. (2022). Total marrow and lymphoid irradiation as conditioning in haploidentical transplant with posttransplant cyclophosphamide. Blood Advances. 6(14). 4098–4106.
3.
Wang, Xiuli, Ryan Urak, Miriam Walter, et al.. (2022). Large-scale manufacturing and characterization of CMV-CD19CAR T cells. Journal for ImmunoTherapy of Cancer. 10(1). e003461–e003461.
4.
Malki, Monzr M. Al, Ni‐Chun Tsai, Joycelynne Palmer, et al.. (2021). Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant. Blood Advances. 5(12). 2650–2659.
5.
Ali, Haris, Ni‐Chun Tsai, Timothy W. Synold, et al.. (2021). Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study. Blood Advances. 6(5). 1444–1453.
6.
Malki, Monzr M. Al, Joo Y. Song, Dongyun Yang, et al.. (2020). Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(9). 1697–1703.
7.
Mei, Matthew, Ni‐Chun Tsai, Sally Mokhtari, et al.. (2020). Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation. 26(8). 1425–1432.
8.
Salhotra, Amandeep, Dongyun Yang, Sally Mokhtari, et al.. (2020). Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation. 26(6). 1084–1090.
9.
Nakamura, Ryotaro, Ketevan Gendzekhadze, Joycelynne Palmer, et al.. (2019). Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation. Leukemia Research. 87. 106230–106230.
10.
Malki, Monzr M. Al, Ketevan Gendzekhadze, Tracey Stiller, et al.. (2019). Protective effect of HLA-DPB1 mismatch remains valid in reduced-intensity conditioning unrelated donor hematopoietic cell transplantation. Bone Marrow Transplantation. 55(2). 409–418.
11.
Ali, Haris, Ibrahim Aldoss, Dongyun Yang, et al.. (2019). MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen. Blood Advances. 3(1). 83–95.
12.
Wang, Xiuli, Miriam Walter, Ryan Urak, et al.. (2019). Large-Scale Manufacturing of CMV-CD19CAR T Cells and Characterization of Their Biologic and Immunologic Properties. Blood. 134(Supplement_1). 3247–3247.
13.
Salhotra, Amandeep, Dongyun Yang, Sally Mokhtari, et al.. (2019). A Retrospective Study of Blinatumomab Based Salvage Regimen As a Bridge to Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Relapsed and Refractory ALL. Biology of Blood and Marrow Transplantation. 25(3). S101–S102.
14.
Malki, Monzr M. Al, Ketevan Gendzekhadze, Dongyun Yang, et al.. (2019). Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Using Tacrolimus/Sirolimus-based GvHD Prophylaxis: Impact of HLA Mismatch. Transplantation. 104(5). 1070–1080.
15.
Dadwal, Sanjeet, et al.. (2018). A Machine-Learning Sepsis Prediction Model for Patients Undergoing Hematopoietic Cell Transplantation. Blood. 132(Supplement 1). 711–711.
16.
Salhotra, Amandeep, Matthew Mei, Tracey Stiller, et al.. (2018). Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD Prophylaxis. Biology of Blood and Marrow Transplantation. 25(2). 287–292.
17.
Modi, Badri, Dongyun Yang, Jeremy Klein, et al.. (2018). Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 25(2). 265–269.
18.
Dadwal, Sanjeet, et al.. (2018). A Dynamic Machine-Learning Based Prediction Model for Sepsis in Patients Undergoing Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(3). S373–S374.
19.
Malki, Monzr M. Al, Joo Y. Song, Dongyun Yang, et al.. (2017). Transfusion- Related Iron Overload (TRIO) Is Associated with Delayed Engraftment and Increased Non Relapse Mortality (NRM) in Patients Undergoing Umbilical Cord Blood (UCB) Hematopoietic Cell Transplantation (HCT). Blood. 130. 3212–3212.
20.
Malki, Monzr M. Al, Sanjeet Dadwal, Dongyun Yang, et al.. (2017). High Incidence of CMV Reactivation after Haploidentical Donor Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide, and Its Impact on Transplant Outcomes. Blood. 130. 4494.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Igor‐Wolfgang Blau Breakdown of academic impact, for papers by Apostolia Papalexandri Breakdown of academic impact, for papers by Takanori Teshima Breakdown of academic impact, for papers by Petter Svenberg Breakdown of academic impact, for papers by C. Filì Breakdown of academic impact, for papers by L-P Xu Breakdown of academic impact, for papers by D.C. Setubal Breakdown of academic impact, for papers by M. Schaffer Breakdown of academic impact, for papers by Jeremy Ramdial Breakdown of academic impact, for papers by S. Vigouroux